Carmen Bergom, MD, PhD, MPhil
Associate Professor, Radiation Oncology and Pharmacology and Toxicology
PhD, Cell Biology, Medical College of Wisconsin, Milwaukee, WI 2006
MPhil, Epidemiology, Cambridge University, Cambridge, UK, 1999
SB, Chemical Engineering and Biology, MIT, Cambridge, MA, 1988
Internal Medicine, Saint Luke's Hospital, Milwaukee, Wisconsin (2009)
Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin (2013)
Radiation Oncology, American Board of Radiology (2014)
The Bergom laboratory embraces collaborative research and also prioritizes the education and training of students and post-doctoral fellows.
This diagram outlines the two main arms of the laboratory (Figure 1).
We have a research program focusing on using unique genetic models and next generation sequencing to enhance the therapeutic ratio of radiation and chemotherapy. Our research program uses these models to identify targets that will allow better tailored radiation therapy and chemotherapy, by enhancing tumor responses to therapy and minimizing radiation- and chemotherapy-induced side effects, specifically treatment-induced cardiotoxicity. Our tumor studies are specifically focusing on the role of the tumor microenvironment in breast cancer treatment responses. The goals of these studies are to identify predictive and prognostic features of breast cancer to better classify and treat breast and other cancers, and ultimately to identify new treatment strategies to improve patient outcomes.
(Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, Sawakuchi GO, Shaitelman SF, Powell SN, Woodward WA.) Int J Radiat Oncol Biol Phys. 2019 Aug 02.
(Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ.) Breast Cancer Res Treat. 2019 Aug;177(1):77-91.
(Frebault J, Bergom C, Kong AL.) Curr Oncol Rep. 2019 Jun 25;21(8):69.
(Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM.) Clin Lung Cancer. 2019 Jun 05.
(Desai N, Currey A, Kelly T, Bergom C.) Adv Radiat Oncol. 2019 Apr-Jun;4(2):246-252.
(Ferrigni E, Bergom C, Yin Z, Szabo A, Kong AL.) Clin Breast Cancer. 2019 Jun;19(3):157-164.
(Jacobs ER, Narayanan J, Fish BL, Gao F, Harmann LM, Bergom C, Gasperetti T, Strande JL, Medhora M.) Health Phys. 2019 Apr;116(4):558-565.
(Bergom C, Vogel WV.) Int J Radiat Oncol Biol Phys. 2019 03 01;103(3):592-594.
(Amin NP, Remick J, Agarwal M, Desai NA, Bergom C, Simone CB 2nd.) Am J Clin Oncol. 2019 Feb;42(2):208-214.
(Flister MJ, Joshi A, Bergom C, Rui H.) Methods Mol Biol. 2019;2018:249-267.
(Currey A, Patten CR, Bergom C, Wilson JF, Kong AL.) Breast J. 2018 11;24(6):902-910.
(Jagtap J, Sharma G, Parchur AK, Gogineni V, Bergom C, White S, Flister MJ, Joshi A.) Biomed Opt Express. 2018 06 01;9(6):2543.